Filing Details

Accession Number:
0001209191-22-019202
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-03-16 16:04:49
Reporting Period:
2022-03-15
Accepted Time:
2022-03-16 16:04:49
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1808158 Repare Therapeutics Inc. RPTX Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1815366 Michael Zinda C/O Repare Therapeutics Inc.
7210 Frederick-Banting, Suite 100
St-Laurent A8 H4S 2A1
Evp, Chief Science Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Shares Disposition 2022-03-15 533 $11.30 46,041 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person.